Most Read News

Institutional investors displayed the most interest, subscribing 8.91 times the allotted quota, while non-institutional investors bought 6.93 times the portion set aside for them.

The February U.S. consumer price index (CPI) report is scheduled to be released at 12:30 GMT. It is anticipated to increase by 0.4% for the month and maintain the 3.1% annual growth rate.

According to a Moneycontrol story from April 17, Sheares Healthcare wants to increase its ownership of Medica to 90% by giving Chairman and important Founder Dr. Alok Roy and associated companies a way out. The deal eventually came to pass.

These transactions are frequently carried out below the going rate in the market. The transaction's specifics could yet alter, according to Bloomberg, and depending on the state of the market, the offering's launch could extend into next week.

Against its annual contracted value of USD50m supplies for Librela, Syngene has supplied USD94m worth of Librela to Zoetis over the past 13 months, which likely implies that Librela supplies to Zoetis will continue to taper off in CY24 and will present a tough base for Syngene going ahead. Syngene shipped just USD2m worth of Librela in Feb’24 vs USD21/13m in Dec’23/Jan’24 respectively.

According to the filing, Power Grid would own 74% of the joint venture, with RRVPNL owning 26%.

The firms include Topline Industries, Aditya Polytechnic, Aditya Industries, and Sainath Polymers.

Atish Majumdar, Senior President of Sales and Marketing at Mankind Pharma, stated that the dual mechanism of action and user-friendly design of Symbicort, housed in a single inhaler, has the potential to significantly assist patients in handling these conditions and enhancing their quality of life. The extensive outreach efforts of our field forces aim to enhance accessibility in both urban and rural markets.

The month of February 2024 saw record SIP inflows despite it being a shorter month.

In a press release, the company stated that the merger would establish a cohesive and sizable entity, endowed with enhanced financial strength and flexibility, providing direct access to capital. This strategic move is expected to empower the company to optimize the utilization and allocation of capital, thereby maximizing its potential to capitalize on opportunities.